Home > Healthcare > Pharmaceuticals > Finished Drug Form > Injectable Contraceptives Market
Injectable Contraceptives Market Size
- Report ID: GMI6602
- Published Date: Aug 2023
- Report Format: PDF
Injectable Contraceptives Market Size
Injectable Contraceptives Market size was valued to be USD 339.5 million in 2022 and is predicted to experience a sustainable growth of CAGR 3.5% from 2023 to 2032. Some of the major factors contributing to the growth of global market are growing awareness about family planning that is leading to an increase in awareness about benefits of injectable. Furthermore, the efforts undertaken by government and other organisations to enhance the availability of injectable contraceptives are contributing to the market expansion.
Injectable contraceptives are a type of birth control method that involves the administration of hormones through an injection to prevent pregnancy. These hormones typically include progestin, a synthetic form of the hormone progesterone. Injectable contraceptives are mainly available in two forms, depot medroxyprogesterone acetate (DMPA) and norethisterone enanthate (NET-EN).
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Injectable Contraceptives Market Size in 2022: | USD 339.5 Million |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 3.5% |
| 2032 Value Projection: | USD 477.3 Million |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 208 |
| Tables, Charts & Figures: | 309 |
| Segments covered: | Type, Age Group, Duration of Action, End-user, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Injectable Contraceptives Market Scope
